Novo Nordisk (NVO) PT Raised to $45 at BMO Capital
BMO Capital analyst Evan Seigerman ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)